|
ZSCAN22 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.102500E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.05849999999064E-05 |
| Normal-vs-Stage2 |
2.078600E-01 |
| Normal-vs-Stage3 |
6.079200E-01 |
| Normal-vs-Stage4 |
7.383800E-01 |
| Stage1-vs-Stage2 |
2.777000E-01 |
| Stage1-vs-Stage3 |
4.182200E-03 |
| Stage1-vs-Stage4 |
1.278560E-03 |
| Stage2-vs-Stage3 |
3.994200E-01 |
| Stage2-vs-Stage4 |
3.116800E-01 |
| Stage3-vs-Stage4 |
8.412600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.836000E-03 |
| Normal-vs-AfricanAmerican |
1.106850E-01 |
| Normal-vs-Asian |
4.399900E-02 |
| Caucasian-vs-AfricanAmerican |
9.285200E-01 |
| Caucasian-vs-Asian |
2.869800E-02 |
| AfricanAmerican-vs-Asian |
4.949800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.519860E-02 |
| Normal-vs-Female |
3.901600E-03 |
| Male-vs-Female |
4.915600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.691800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.197700E-04 |
| Normal-vs-Age(61-80Yrs) |
8.760000E-02 |
| Normal-vs-Age(81-100Yrs) |
9.098600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.533200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.121400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.491000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.639910E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.509400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.908200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.64349999948388E-07 |
| Normal-vs-Grade 2 |
2.32679999999652E-05 |
| Normal-vs-Grade 3 |
2.612200E-01 |
| Normal-vs-Grade 4 |
8.949200E-01 |
| Grade 1-vs-Grade 2 |
3.120100E-02 |
| Grade 1-vs-Grade 3 |
1.618550E-03 |
| Grade 1-vs-Grade 4 |
2.26269999999973E-05 |
| Grade 2-vs-Grade 3 |
1.683040E-03 |
| Grade 2-vs-Grade 4 |
1.414370E-04 |
| Grade 3-vs-Grade 4 |
2.618000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.86200000032544E-07 |
| Normal-vs-ccB subtype |
7.679600E-01 |
| ccA subtype-vs-ccB subtype |
3.73629999994574E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.398100E-02 |
| Normal-vs-N1 |
4.754600E-01 |
| N0-vs-N1 |
2.154000E-01 |
|
|
